JP2011523945A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011523945A5 JP2011523945A5 JP2011510650A JP2011510650A JP2011523945A5 JP 2011523945 A5 JP2011523945 A5 JP 2011523945A5 JP 2011510650 A JP2011510650 A JP 2011510650A JP 2011510650 A JP2011510650 A JP 2011510650A JP 2011523945 A5 JP2011523945 A5 JP 2011523945A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- group
- unsubstituted
- compound
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- IRYJRGCIQBGHIV-UHFFFAOYSA-N CC(C)(C(N1C)=O)OC1=O Chemical compound CC(C)(C(N1C)=O)OC1=O IRYJRGCIQBGHIV-UHFFFAOYSA-N 0.000 description 1
- 0 CC(N1C)=C(*)SC1=O Chemical compound CC(N1C)=C(*)SC1=O 0.000 description 1
- LVHVTYQPRMNICT-UHFFFAOYSA-N CCOC(C=CN1C)=NC1=O Chemical compound CCOC(C=CN1C)=NC1=O LVHVTYQPRMNICT-UHFFFAOYSA-N 0.000 description 1
- UVTUYTIMHXWMRL-UHFFFAOYSA-N CN(C(SC)=NS1)C1=O Chemical compound CN(C(SC)=NS1)C1=O UVTUYTIMHXWMRL-UHFFFAOYSA-N 0.000 description 1
- DHGBSOMRGXWRSE-UHFFFAOYSA-N CN(C)C(C=CN1C)=NC1=O Chemical compound CN(C)C(C=CN1C)=NC1=O DHGBSOMRGXWRSE-UHFFFAOYSA-N 0.000 description 1
- FNRIYKOFDSKGTF-UHFFFAOYSA-N CN(C=CC(N1CCCC1)=N1)C1=O Chemical compound CN(C=CC(N1CCCC1)=N1)C1=O FNRIYKOFDSKGTF-UHFFFAOYSA-N 0.000 description 1
- QXIHJEWUXUZTHM-UHFFFAOYSA-N CN(C=CC([n]1ncnc1)=N1)C1=O Chemical compound CN(C=CC([n]1ncnc1)=N1)C1=O QXIHJEWUXUZTHM-UHFFFAOYSA-N 0.000 description 1
- CVUKXDYMTQWGBD-UHFFFAOYSA-N CN(CC(N1S)=O)C1=O Chemical compound CN(CC(N1S)=O)C1=O CVUKXDYMTQWGBD-UHFFFAOYSA-N 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N CN(CCN1C)C1=O Chemical compound CN(CCN1C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- MTAUWGJDZIAUQM-UHFFFAOYSA-N CN1N=C(C=CC=C2)N2C1=O Chemical compound CN1N=C(C=CC=C2)N2C1=O MTAUWGJDZIAUQM-UHFFFAOYSA-N 0.000 description 1
- IIFFJWZFJVKHFN-UHFFFAOYSA-N CN1NC2C=CC=CC2C1=O Chemical compound CN1NC2C=CC=CC2C1=O IIFFJWZFJVKHFN-UHFFFAOYSA-N 0.000 description 1
- DBJMEBUKQVZWMD-UHFFFAOYSA-N CN1c(cccc2)c2OCC1=O Chemical compound CN1c(cccc2)c2OCC1=O DBJMEBUKQVZWMD-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5443708P | 2008-05-19 | 2008-05-19 | |
| US5443208P | 2008-05-19 | 2008-05-19 | |
| US61/054,437 | 2008-05-19 | ||
| US61/054,432 | 2008-05-19 | ||
| PCT/US2009/044525 WO2009143156A2 (en) | 2008-05-19 | 2009-05-19 | IMIDAZO[1,2-a]PYRIDINE COMPOUNDS |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015090193A Division JP6211556B2 (ja) | 2008-05-19 | 2015-04-27 | イミダゾ［１，２−ａ］ピリジン化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011523945A JP2011523945A (ja) | 2011-08-25 |
| JP2011523945A5 true JP2011523945A5 (https=) | 2012-07-05 |
| JP5774982B2 JP5774982B2 (ja) | 2015-09-09 |
Family
ID=41031732
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011510650A Expired - Fee Related JP5774982B2 (ja) | 2008-05-19 | 2009-05-19 | イミダゾ［１，２−ａ］ピリジン化合物 |
| JP2015090193A Active JP6211556B2 (ja) | 2008-05-19 | 2015-04-27 | イミダゾ［１，２−ａ］ピリジン化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015090193A Active JP6211556B2 (ja) | 2008-05-19 | 2015-04-27 | イミダゾ［１，２−ａ］ピリジン化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US8497278B2 (https=) |
| EP (1) | EP2300470A2 (https=) |
| JP (2) | JP5774982B2 (https=) |
| AU (1) | AU2009249186B2 (https=) |
| CA (1) | CA2724842A1 (https=) |
| WO (1) | WO2009143156A2 (https=) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200918102A (en) * | 2007-10-24 | 2009-05-01 | Nihon Mediphysics Co Ltd | Novel compound having affinity for amyloid |
| PH12012500778A1 (en) | 2009-10-30 | 2012-11-26 | Janssen Pharmaceutica Nv | IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS |
| EP2496578A4 (en) | 2009-11-05 | 2013-08-21 | Univ Notre Dame Du Lac | IMIDAZO [1,2-A] PYRIDINE COMPOUNDS, THEIR SYNTHESIS AND METHODS OF USE THEREOF |
| AR080754A1 (es) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 |
| NZ603789A (en) * | 2010-05-26 | 2015-03-27 | Sunovion Pharmaceuticals Inc | Heteroaryl compounds and methods of use thereof |
| CA2831356A1 (en) * | 2011-03-31 | 2012-10-04 | Emblem Technology Transfer Gmbh | Imidazo [1,2-a]pyridine_compounds for use in therapy |
| BR112013033375B1 (pt) | 2011-06-27 | 2022-05-10 | Janssen Pharmaceutica N.V | Derivados de 1-aril-4-metil-[1,2,4]triazolo[4,3-a]quinoxa-lina, seu uso, composição farmacêutica que os compreende, processo de preparação dos mesmos, solução estéril e composto intermediário |
| RU2014150494A (ru) * | 2012-05-30 | 2016-07-20 | Ф. Хоффманн-Ля Рош Аг | Пирролидиногетероциклы |
| HK1206250A1 (en) | 2012-06-26 | 2016-01-08 | Janssen Pharmaceutica Nv | Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl-[1,2,4] triazolo [4,3-a] quinoxaline compounds and ped 10 inhibitors for use in the treatment of neurological or metabolic disorders |
| WO2014009305A1 (en) | 2012-07-09 | 2014-01-16 | Janssen Pharmaceutica Nv | Inhibitors of phosphodiesterase 10 enzyme |
| EP3004088A1 (en) | 2013-05-24 | 2016-04-13 | Iomet Pharma Ltd. | Slc2a transporter inhibitors |
| KR20180053386A (ko) | 2015-09-17 | 2018-05-21 | 마빈 제이. 밀러 | 마이코박테리아 감염에 대해 유용한 벤질 아민-함유 헤테로사이클릭 화합물 및 조성물 |
| PL3153506T3 (pl) * | 2015-10-07 | 2018-05-30 | Sanko Tekstil Isletmeleri San. Ve Tic. A.S. | Izoksazole, sposób ich wytwarzania i ich zastosowania |
| EP3365340B1 (en) | 2015-10-19 | 2022-08-10 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| US20170145025A1 (en) | 2015-11-19 | 2017-05-25 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| US10414765B2 (en) | 2015-12-10 | 2019-09-17 | Bayer Pharma Aktiengesellschaft | Substituted perhydropyrrolo[3,4-c]pyrrole derivatives and the use of same |
| WO2017097792A1 (de) | 2015-12-10 | 2017-06-15 | Bayer Pharma Aktiengesellschaft | 2-phenyl-3-(piperazinomethyl)imidazo[1,2-a]pyridin-derivate als blocker der task-1 und task-2 kanäle zur behandlung von schlafbedingten atemstörungen |
| ES2916874T3 (es) | 2015-12-17 | 2022-07-06 | Incyte Corp | Derivados de N-fenil-piridina-2-carboxamida y su uso como moduladores de la interacción proteína/proteína PD-1/PD-L1 |
| AU2016379372A1 (en) | 2015-12-22 | 2018-08-02 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| ES2906460T3 (es) | 2016-05-06 | 2022-04-18 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| ES2905980T3 (es) | 2016-05-26 | 2022-04-12 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| BR112018076534A2 (pt) | 2016-06-20 | 2019-04-02 | Incyte Corporation | compostos heterocíclicos como imunomoduladores |
| MA45669A (fr) | 2016-07-14 | 2019-05-22 | Incyte Corp | Composés hétérocycliques utilisés comme immunomodulateurs |
| JOP20190005A1 (ar) * | 2016-07-20 | 2019-01-20 | Bayer Ag | مركبات ديازاهيترو ثنائية الحلقة مستبدلة واستخداماتها |
| CN106279123B (zh) * | 2016-08-15 | 2018-09-04 | 郑州大学 | 3-(苯磺酰甲基)咪唑并杂环类化合物及其合成方法 |
| ES2941716T3 (es) | 2016-08-29 | 2023-05-25 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| EA202192558A1 (ru) * | 2016-12-14 | 2021-12-07 | Байер Акциенгезельшафт | Замещенные диазагетеробициклические соединения и их применение |
| WO2018119286A1 (en) | 2016-12-22 | 2018-06-28 | Incyte Corporation | Bicyclic heteroaromatic compounds as immunomodulators |
| ES2899402T3 (es) | 2016-12-22 | 2022-03-11 | Incyte Corp | Derivados de piridina como inmunomoduladores |
| EP3558990B1 (en) | 2016-12-22 | 2022-08-10 | Incyte Corporation | Tetrahydro imidazo[4,5-c]pyridine derivatives as pd-l1 internalization inducers |
| ES2874756T3 (es) | 2016-12-22 | 2021-11-05 | Incyte Corp | Derivados de triazolo[1,5-A]piridina como inmunomoduladores |
| AU2017382870B2 (en) | 2016-12-22 | 2022-03-24 | Incyte Corporation | Benzooxazole derivatives as immunomodulators |
| CN107163039A (zh) * | 2017-05-11 | 2017-09-15 | 浙江工业大学 | 一种6‑甲基‑2‑对甲苯基咪唑并[1,2‑a]吡啶‑3‑甲醛的制备方法 |
| JOP20190284A1 (ar) | 2017-06-14 | 2019-12-11 | Bayer Pharma AG | مركبات إيميدازوبيريميدين مستبدلة بديازا ثنائي الحلقة واستخدامها للمعالجة من اضطرابات التنفس |
| WO2018227427A1 (en) | 2017-06-14 | 2018-12-20 | Bayer Aktiengesellschaft | Substituted bridged diazepane derivatives and use thereof |
| CR20200520A (es) | 2018-03-30 | 2021-03-09 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| WO2019217821A1 (en) | 2018-05-11 | 2019-11-14 | Incyte Corporation | Tetrahydro-imidazo[4,5-c]pyridine derivatives as pd-l1 immunomodulators |
| WO2019238633A1 (en) * | 2018-06-13 | 2019-12-19 | F. Hoffmann-La Roche Ag | New isoxazolyl ether derivatives as gaba a alpha5 pam |
| CN110964020B (zh) * | 2018-09-28 | 2022-06-14 | 中国科学院大连化学物理研究所 | 一种制备3’,4’-二氢螺[吲哚啉-3,2’-吡咯]化合物的方法 |
| WO2020135771A1 (zh) * | 2018-12-29 | 2020-07-02 | 武汉朗来科技发展有限公司 | 杂环类化合物、中间体、其制备方法及应用 |
| EP4010342A1 (en) | 2019-08-09 | 2022-06-15 | Incyte Corporation | Salts of a pd-1/pd-l1 inhibitor |
| WO2021067217A1 (en) | 2019-09-30 | 2021-04-08 | Incyte Corporation | Pyrido[3,2-d]pyrimidine compounds as immunomodulators |
| BR112022009031A2 (pt) | 2019-11-11 | 2022-10-11 | Incyte Corp | Sais e formas cristalinas de um inibidor de pd-1/pd-l1 |
| CN114380819B (zh) * | 2020-10-22 | 2024-08-23 | 鲁南制药集团股份有限公司 | 一种唑吡坦中间体化合物 |
| WO2022099075A1 (en) | 2020-11-06 | 2022-05-12 | Incyte Corporation | Crystalline form of a pd-1/pd-l1 inhibitor |
| US11780836B2 (en) | 2020-11-06 | 2023-10-10 | Incyte Corporation | Process of preparing a PD-1/PD-L1 inhibitor |
| US11866434B2 (en) | 2020-11-06 | 2024-01-09 | Incyte Corporation | Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB991589A (en) * | 1963-04-30 | 1965-05-12 | Selvi & C Lab Bioterapico | Novel [1,2-ª‡]imidazopyridines and a process for the manufacture thereof |
| US3489755A (en) * | 1966-08-03 | 1970-01-13 | Pfizer & Co C | Imidazo (1,2-b) pyridazines |
| US4242513A (en) * | 1979-03-05 | 1980-12-30 | Appleton Papers Inc. | Lactone compounds containing a heterocyclic radical |
| GB8305245D0 (en) * | 1983-02-25 | 1983-03-30 | Fujisawa Pharmaceutical Co | Imidazo-heterocyclic compounds |
| FR2568880B1 (fr) | 1984-08-07 | 1986-12-12 | Synthelabo | Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique |
| ATE62687T1 (de) * | 1986-01-22 | 1991-05-15 | Synthelabo | Acylaminomethylimidazo(1,2-a>pyrimidinderivate, ihre herstellung und therapeutische verwendung. |
| WO1989001333A1 (en) * | 1987-08-07 | 1989-02-23 | The Australian National University | IMIDAZO[1,2-b]PYRIDAZINES |
| IN179789B (https=) * | 1992-02-10 | 1997-12-06 | Council Scient Ind Res | |
| FR2714907B1 (fr) * | 1994-01-07 | 1996-03-29 | Union Pharma Scient Appl | Nouveaux dérivés de l'Adénosine, leurs procédés de préparation, compositions pharmaceutiques les contenant. |
| JPH09176165A (ja) * | 1995-12-25 | 1997-07-08 | Nippon Nohyaku Co Ltd | イミダゾ［１，２−ａ］ピリジン誘導体、その製法およびその用途 |
| AU2001270297A1 (en) * | 2000-06-30 | 2002-01-14 | Neurogen Corporation | 2-phenylimidazo(1,2-a)pyridine derivatives: a new class of gaba brain receptor ligands |
| US6514969B2 (en) * | 2000-08-16 | 2003-02-04 | Boehringer Ingelheim Pharma Kg | β-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions |
| DE10040016A1 (de) | 2000-08-16 | 2002-02-28 | Boehringer Ingelheim Pharma | Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| SE0100567D0 (sv) * | 2001-02-20 | 2001-02-20 | Astrazeneca Ab | Compounds |
| JP2007509960A (ja) * | 2003-10-28 | 2007-04-19 | セプラコア インコーポレーテッド | イミダゾ［１，２−ａ］ピリジン抗不安薬 |
| US20090023737A1 (en) * | 2004-02-12 | 2009-01-22 | Neurogen Corporation | Imidazo-Pyridazines, Triazolo-Pyridazines and Related Benzodiazepine Receptor Ligands |
| DK1814880T3 (da) | 2004-11-11 | 2009-05-18 | Ferrer Int | Imidazo[1,2-a]pyridinforbindelser, og sammensætninger, anvendelser og fremgangsmåder, der er forbundet dermed |
| US7666880B2 (en) * | 2005-03-21 | 2010-02-23 | S*Bio Pte Ltd. | Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications |
| TW200714600A (en) | 2005-03-21 | 2007-04-16 | S Bio Pte Ltd | Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications |
| EP2308870A3 (en) | 2005-06-01 | 2011-10-19 | UCB Pharma S.A. | 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses |
| EP1910385B1 (en) * | 2005-08-04 | 2013-07-24 | Sirtris Pharmaceuticals, Inc. | Benzothiazoles and thiazolopyridines as sirtuin modulators |
| WO2007067511A2 (en) * | 2005-12-06 | 2007-06-14 | Merck & Co., Inc. | Morpholine carboxamide prokineticin receptor antagonists |
| EP1845098A1 (en) * | 2006-03-29 | 2007-10-17 | Ferrer Internacional, S.A. | Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands |
| CN101528226B (zh) * | 2006-08-24 | 2012-01-11 | 澳大利亚核科学技术组织 | 靶向外周苯二氮卓受体的氟化配体 |
| BRPI0718029A2 (pt) * | 2006-11-06 | 2013-11-26 | Supergen Inc | Derivados de imidazo(1,2-b)piridazina e pirazolo(1,5-a)pirimidina e seu uso como inibidores da proteína cinase |
| EP1974729A1 (en) | 2007-03-28 | 2008-10-01 | Santhera Pharmaceuticals (Schweiz) AG | Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists |
| CA2709784A1 (en) * | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
-
2009
- 2009-05-19 CA CA2724842A patent/CA2724842A1/en not_active Abandoned
- 2009-05-19 AU AU2009249186A patent/AU2009249186B2/en not_active Ceased
- 2009-05-19 WO PCT/US2009/044525 patent/WO2009143156A2/en not_active Ceased
- 2009-05-19 EP EP09751384A patent/EP2300470A2/en not_active Ceased
- 2009-05-19 US US12/993,679 patent/US8497278B2/en not_active Expired - Fee Related
- 2009-05-19 JP JP2011510650A patent/JP5774982B2/ja not_active Expired - Fee Related
-
2013
- 2013-06-24 US US13/925,108 patent/US20130289013A1/en not_active Abandoned
-
2015
- 2015-04-27 JP JP2015090193A patent/JP6211556B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011523945A5 (https=) | ||
| ES2769181T3 (es) | Compuestos de piridina y de pirazina sustituidos como inhibidores de PDE4 | |
| CA3011189C (en) | 5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines | |
| JP5966014B2 (ja) | 新規トリフルオロメチル−オキサジアゾール誘導体および疾患の処置におけるその使用 | |
| ES2638850T3 (es) | Compuestos de azabenzimidazol como inhibidores de las isoenzimas de la PDE4 para el tratamiento de trastornos del SNC y otros trastornos | |
| ES2696351T3 (es) | Compuestos de pirazol y su uso como bloqueadores de canales de calcio de tipo T | |
| JP6964576B2 (ja) | 置換４−アザインドール及びｇｌｕｎ２ｂ受容体調節因子としてのそれらの使用 | |
| TWI791581B (zh) | 二酮 | |
| JP2020506946A (ja) | がん治療のための２−ヘテロアリール−３−オキソ−２，３−ジヒドロピリダジン−４−カルボキサミド類 | |
| EA030410B1 (ru) | Замещенные конденсированные гетероциклы в качестве модуляторов gpr119 для лечения диабета, ожирения, дислипидемии и связанных нарушений | |
| JP2008513498A5 (https=) | ||
| JP7744350B2 (ja) | 置換ピラゾロ－ピリミジンおよびその使用 | |
| KR20150107871A (ko) | 티아디아졸 유사체 및 smn-결핍-관련-상태의 치료 방법 | |
| EA015488B1 (ru) | Содержащие диариловый эфир соединения мочевины | |
| JP2019163330A (ja) | トロポミオシン関連キナーゼ（ｔｒｋ）阻害剤 | |
| CA2988637A1 (en) | Aromatic sulfonamide derivatives | |
| EA031201B1 (ru) | Соединения имидазопиридазина | |
| KR20180107232A (ko) | 오렉신 수용체 조정제로서의 할로-치환된 피페리딘 | |
| EP2934536B1 (en) | FACTOR IXa INHIBITORS | |
| CN100572381C (zh) | 吡唑并二氮杂萘衍生物 | |
| WO2014069554A1 (ja) | キヌクリジンアミド誘導体及びその医薬用途 | |
| CN110724075B (zh) | 酰胺类化合物、包含其的药物组合物、其制备方法及其用途 | |
| HK40075899A (en) | Substituted pyrazolo-pyrimidines and uses thereof | |
| HK1206008B (en) | Diazepinone derivatives useful for the treatment of fragile x syndrome, parkinsons or reflux disease |